30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Inkine Pharmaceutical Company Inc (INKP)

Track

Stock chart
Ticker: INKP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
STAGNARO THOMAS P
1 sale — total 53,300 USD
Planned sale 3 Jan 2005
Value US$3,816,238.20 | Price 155.58 | Shares 60,708
Planned sale 15 Dec 2004
Value US$3,072,414.83 | Price 293.13 | Shares 6,071
Sale 2 Dec 2004
Value US$13,700.00 | Price 5.48 | Shares 2,500
Sale 1 Dec 2004
Value US$28,236.00 | Price 5.43 | Shares 5,200
Sale 17 Nov 2004
Value US$1,680.00 | Price 5.60 | Shares 300
Buy 12 Nov 2004
Value US$52,500.00 | Price 5.25 | Shares 10,000
Sale 9 Nov 2004
Value US$477,000.00 | Price 5.30 | Shares 90,000
Sale 6 Feb 2004
Value US$13,416.00 | Price 5.59 | Shares 2,400
Sale 4 Feb 2004
Value US$6,138.00 | Price 5.58 | Shares 1,100
Sale 3 Feb 2004
Value US$11,180.00 | Price 5.59 | Shares 2,000
Sale 2 Feb 2004
Value US$8,370.00 | Price 5.58 | Shares 1,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2005-01-05 2005-01-03 PlS Planned sale STAGNARO THOMAS P Non-Executive Director
60,708 +43.8%
155.58
US$3,816,238 		60,708 +43.8% 155.58 US$3,816,238
2004-12-17 2004-12-15 PlS Planned sale STAGNARO THOMAS P Non-Executive Director
6,071 +0.1%
293.13
US$3,072,415 		6,071 +0.1% 293.13 US$3,072,415
2004-12-03 2004-12-02 S Sale LESHUFY J R Non-Executive Director
31,337 +45.4%
430.88
US$1,718,292 		31,337 +45.4% 430.88 US$1,718,292
2004-12-03 2004-12-01 S Sale LESHUFY J R Non-Executive Director
5,200 -21.1%
5.43
US$28,236 		5,200 -21.1% 5.43 US$28,236
2004-11-22 2004-11-17 S Sale LESHUFY J R Non-Executive Director
300 -1.2%
5.60
US$1,680 		300 -1.2% 5.60 US$1,680
2004-11-12 2004-11-12 B Purchase HARRAL WILLIAM III Non-Executive Director
10,000 +100.0%
5.25
US$52,500 		10,000 +100.0% 5.25 US$52,500
2004-11-12 2004-11-09 S Sale APPLE ROBERT F

Chief Operating and Financial

Executive Director
90,000 -94.7%
5.30
US$477,000 		90,000 -94.7% 5.30 US$477,000
2004-02-09 2004-02-06 S Sale LESHUFY J R
2,400 -11.8%
5.59
US$13,416 		2,400 -11.8% 5.59 US$13,416
2004-02-09 2004-02-04 S Sale LESHUFY J R
1,100 -5.1%
5.58
US$6,138 		1,100 -5.1% 5.58 US$6,138
2004-02-09 2004-02-03 S Sale LESHUFY J R
2,000 -8.5%
5.59
US$11,180 		2,000 -8.5% 5.59 US$11,180
2004-02-09 2004-02-02 S Sale LESHUFY J R
1,500 -6.0%
5.58
US$8,370 		1,500 -6.0% 5.58 US$8,370
Explore more

More insider trading research around Inkine Pharmaceutical Company Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America